|
Market Cap (17-May) $49,668,124 (678th) |
Close (30-Jun) $0.250 |
Volume (30-Jun) 540,651 |
Shortsold (11-Feb) 2,268 (0.00%) (651st) |
|
52w High $0.160 |
52w Low $0.057 |
P/E - |
EPS -0.02 |
DTZ released this announcement to the ASX on 3 May 2021, 9:19. The announcement is marked as price sensitive, and is 10 page(s) in length and 707.72kb in size.
You can view all announcements from DTZ and see how they appear on a price chart on the announcements page.
At the date of this announcement, DTZ was 0.001% short sold according to ASIC data. It was ranked the 643rd most shorted stock on the ASX. It remains ranked 651st as of the latest reported data (11 February 2025).
| Other Recent Announcements from DTZ | |
|---|---|
| Cleansing Statement | 30 June 2023, 10:35 |
| Application for quotation of securities - DTZ | 30 June 2023, 10:33 |
| Change of Director's Interest Notice - DE | 22 June 2023, 19:05 |
| Quarterly Report & Appendix 4C Cashflow Report - 31 March 21 | 3 May 2021, 9:19 |
| Dotz and Zohar Dalia Sign Supply and Distribution Agreements | 26 April 2021, 9:16 |
| DTZ Completes Clinical Trial and Submits FDA EUA Application | 7 April 2021, 10:13 |
| Appendix 4G | 31 March 2021, 15:47 |
You must be logged in to post a reply.
